Form EFFECT Jade Biosciences, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 15, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jade Biosciences completes $172.5 million stock offering
- Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
- Grey Wind Capital Partners with Maher Services and F. G. Sullivan to Build a Leading New England Water Well Services Platform
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share